We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

0 hedge funds and large institutions have $0 invested in Akcea Therapeutics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 980 (-98)

100% less capital invested

Capital invested by funds: $287M → $0 (-$287M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
Holders Change
-98
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
98
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MTCM
51
Mint Tower Capital Management
Netherlands
-$346K -19,082 Closed
ProShare Advisors
52
ProShare Advisors
Maryland
-$334K -18,386 Closed
AG
53
Aperio Group
California
-$325K -17,934 Closed
Russell Investments Group
54
Russell Investments Group
United Kingdom
-$317K -17,481 Closed
Tudor Investment Corp
55
Tudor Investment Corp
Connecticut
-$313K -17,228 Closed
Bank of America
56
Bank of America
North Carolina
-$310K -17,114 Closed
Millennium Management
57
Millennium Management
New York
-$294 -16,219 Closed
AQR Capital Management
58
AQR Capital Management
Connecticut
-$261K -14,387 Closed
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
-$258K -14,200 Closed
ECM
60
ExodusPoint Capital Management
New York
-$238K -13,111 Closed
Group One Trading
61
Group One Trading
Illinois
-$232K -12,800 Closed
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$215K -11,870 Closed
Verition Fund Management
63
Verition Fund Management
Connecticut
-$206K -11,352 Closed
AIG
64
American International Group
New York
-$179K -9,840 Closed
EPM
65
Equitec Proprietary Markets
Illinois
-$172K -9,500 Closed
Deutsche Bank
66
Deutsche Bank
Germany
-$159K -8,759 Closed
MIM
67
MetLife Investment Management
New Jersey
-$144K -7,945 Closed
TRCT
68
Tower Research Capital (TRC)
New York
-$143K -7,876 Closed
PAM
69
Panagora Asset Management
Massachusetts
-$133K -7,343 Closed
SAM
70
Shell Asset Management
Netherlands
-$133K -7,343 Closed
Bank of Montreal
71
Bank of Montreal
Ontario, Canada
-$118K -6,510 Closed
JP Morgan Chase
72
JP Morgan Chase
New York
-$111K -6,134 Closed
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
-$104K -5,757 Closed
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
-$99K -5,455 Closed
Osaic Holdings
75
Osaic Holdings
Arizona
-$69K -5,000 Closed

AKCA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2020, worth a combined $0 — down 100% from $287M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of AKCA and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2020, down from 98 in Q3 2020.
  • Funds reported $0 of Akcea Therapeutics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Akcea Therapeutics Inc positions in Q4 2020 and 98 closed out, a net change of -98 holders.
  • The largest Akcea Therapeutics Inc seller in Q4 2020 was Fidelity Investments, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2020.